SPIRIVA 18 Microgram Inhalation Powder, Capsule
Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
Характеристики продукта
(SPC)
10-06-2024
Деякі документи на цей товар наразі недоступні. Ви можете надіслати запит до нашої служби підтримки, і ми повідомимо вас, як тільки ми зможемо їх отримати.
Відправляти запит.
Відправляти запит.
Активний інгредієнт:
TIOTROPIUM BROMIDE
Доступна з:
Clear Pharmacy
Код атс:
R03BB04
ІПН (Міжнародна Ім'я):
TIOTROPIUM BROMIDE
Дозування:
18 Microgram
Фармацевтична форма:
Inhalation Powder, Capsule
Тип рецепту:
Product subject to prescription which may be renewed (B)
Терапевтична области:
Anticholinergics
Статус Авторизація:
Authorised
Дата Авторизація:
2011-05-20
Характеристики продукта
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Spiriva 18 microgram, inhalation powder, hard capsule.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each capsule contains 22.5 microgram tiotropium bromide monohydrate equivalent to 18 microgram tiotropium.
The delivered dose (the dose that leaves the mouthpiece of the HandiHaler device) is 10 microgram tiotropium.
Excipient: contains lactose monohydrate
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Inhalation powder, hard capsule.
_Product imported from the United Kingdom and Italy:_
Light green, hard capsules with the product code TI 01 and company logo printed on the capsule.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Tiotropium is indicated as a maintenance bronchodilator treatment to relieve symptoms of patients with chronic
obstructive pulmonary disease (COPD).
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Posology:
_The medicinal product is intended for inhalation use only._
The recommended dosage of tiotropium bromide is inhalation of the contents of one capsule once daily with the
HandiHaler device at the same time of day.
The recommended dose should not be exceeded.
Tiotropium bromide capsules must not be swallowed.
Tiotropium bromide should only be inhaled with the HandiHaler device.
Special populations:
Geriatric patients can use tiotropium bromide at the recommended dose.
Renally impaired patients can use tiotropium bromide at the recommended dose. For patients with moderate to severe
impairment (creatinine clearance
50 ml/min) see section 4.4 and section 5.2
Hepatically impaired patients can use tiotropium bromide at the recommended dose (see section 5.2).
There is no relevant use in the paediatric population (below 18 years) in the indication stated under section 4.1.
Method of a
Прочитайте повний документ
